Wednesday, February 9, 2022

Very Brief Blog: NCI Planning Potential Large Trial in MCED - Multi Cancer Early Detection

On February 3,  2022, I noted that the Biden Moonshot for cancer cures specifically called out MCED as an important area - Multi Cancer Early Detection - here.

Hat's off to the incredible researchers at the healthcare equity research firm Nephron, which uncovered a little-discussed RFI from the NCI in January.   

It's called, "Seeking Input from Multi-Cancer Early Detection Test Developers on Readiness for Participation in an NCI-Sponsored Clinical Utility Randomized Controlled Screening Trial."

See the full RFI information here:

Note that there are several related NCI announcements, highlighted in this announcement, such as 22-010 for biorepositories for MCED and 22-011 on technology for MCED.